SPAC222.08c Antibody

Molecular Identity of SPAC222.08c

SPAC222.08c is a predicted glutamine aminotransferase subunit in Schizosaccharomyces pombe (fission yeast), annotated in the KEGG Vitamin B6 metabolism pathway . Its functional role aligns with pyridoxal phosphate biosynthesis, critical for amino acid metabolism.

Antigen Characteristics

No direct studies on SPAC222.08c antibodies exist, but its protein features can be extrapolated:

• Domain Structure: Predicted catalytic domains for aminotransferase activity.

• Post-Translational Modifications: Phosphorylation sites or interacting partners remain uncharacterized, though proteomic studies in S. pombe highlight analogous regulatory networks .

Potential Applications of SPAC222.08c Antibodies

Antibodies targeting SPAC222.08c could enable:

• Functional Studies: Localization via immunofluorescence or quantification via Western blot in metabolic mutants.

• Protein-Protein Interaction Mapping: Co-immunoprecipitation to identify partners in the Vitamin B6 pathway .

Antibody Development Strategies

While SPAC222.08c antibodies are not commercially documented, phage display (as described in anti-dengue scFv pipelines ) or hybridoma technologies could be employed. Key steps include:

1. Antigen Production: Recombinant SPAC222.08c expression in E. coli or yeast.

2. Epitope Selection: Prioritize conserved regions using alignment tools.

3. Validation: Cross-reactivity testing against S. pombe proteome .

Challenges and Future Directions

• Specificity: Homology to human glutamine aminotransferases necessitates stringent validation .

• Functional Redundancy: S. pombe metabolic pathways often involve paralogs (e.g., SPAC3A11.11c ), complicating phenotypic analyses.

Comparative Insights from Related Systems

Studies on S. pombe sirtuins (e.g., Hst4) demonstrate the utility of chromatin immunoprecipitation (ChIP) for enzyme-substrate mapping . Analogous approaches could resolve SPAC222.08c’s regulatory roles.

Tables of Relevance

Key Interactors of SPAC222.08c (BioGRID Data9)

Related Antibody Technologies